Primary percutaneous coronary intervention for all?

JAMA

Volumn 287, Issue 15, 2002, Pages 1987-1989

  Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOT LYSIS; EDITORIAL; HEART INFARCTION; HUMAN; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

EID: 0037123279     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.15.1987     Document Type: Editorial

References (29)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations
3. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy of acute myocardial infarction: A quantitative review
4. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) trial
5. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction
6. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)
7. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
8. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy
9. The volume of primary angioplasty procedures and survival after acute myocardial infarction
10. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
11. Primary angioplasty for the treatment of acute myocardial infarction: Experience at two community hospitals without cardiac surgery
12. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: A randomized controlled trial
13. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: The PRAGUE study
14. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in high-risk myocardial infarction (Air PAMI Study)
15. Danish Trial in Acute Myocardial Infarction (DANAMI) 2
16. Platelet glycoprotein Ilb/IIIa inhibition with coronary stenting for acute myocardial infarction
17. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction: Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators
18. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
19. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
20. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials
21. The importance of TIMI 3 flow
22. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
23. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
24. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: A randomised trial
25. Assessment of the treatment effect of enoxaparin for unstable Angina/Non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis
26. Updated meta-analysis of primary PCI vs thrombolysis
27. Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial
28. Access to timely and optimal care of patients with acute coronary syndromes - Community planning considerations: A report by the National Heart Attack Alert Program